Literature DB >> 15512902

Reduced NAA in motor and non-motor brain regions in amyotrophic lateral sclerosis: a cross-sectional and longitudinal study.

R R Rule1, J Suhy, N Schuff, D F Gelinas, R G Miller, M W Weiner.   

Abstract

OBJECTIVES: After replication of previous findings we aimed to: 1) determine if previously reported (1)H MRSI differences between ALS patients and control subjects are limited to the motor cortex; and 2) determine the longitudinal metabolic changes corresponding to varying levels of diagnostic certainty.
METHODS: Twenty-one patients with possible/suspected ALS, 24 patients with probable/definite ALS and 17 control subjects underwent multislice (1)H MRSI co-registered with tissue-segmented MRI to obtain concentrations of the brain metabolites N-acetylaspartate (NAA), creatine, and choline in the left and right motor cortex and in gray matter and white matter of non-motor regions in the brain.
RESULTS: In the more affected hemisphere, reductions in the ratios, NAA/Cho and NAA/Cre+Cho were observed both within (12.6% and 9.5% respectively) and outside (9.2% and 7.3% respectively) the motor cortex in probable/definite ALS. However, these reductions were significantly greater within the motor cortex (P<0.05 for NAA/Cho and P<0.005 for NAA/Cre+Cho). Longitudinal changes in NAA were observed at three months within the motor cortex of both possible/suspected ALS patients (P<0.005) and at nine months outside the motor cortex of probable/definite patients (P<0.005). However, there was no clear pattern of progressive change over time.
CONCLUSIONS: NAA ratios are reduced in the motor cortex and outside the motor cortex in ALS, suggesting widespread neuronal injury. Longitudinal changes of NAA are not reliable, suggesting that NAA may not be a useful surrogate marker for treatment trials.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15512902      PMCID: PMC2744639          DOI: 10.1080/14660820410017109

Source DB:  PubMed          Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord        ISSN: 1466-0822


  31 in total

1.  Extramotor involvement in ALS: PET studies with the GABA(A) ligand [(11)C]flumazenil.

Authors:  C M Lloyd; M P Richardson; D J Brooks; A Al-Chalabi; P N Leigh
Journal:  Brain       Date:  2000-11       Impact factor: 13.501

2.  Region and tissue differences of metabolites in normally aged brain using multislice 1H magnetic resonance spectroscopic imaging.

Authors:  N Schuff; F Ezekiel; A C Gamst; D L Amend; A A Capizzano; A A Maudsley; M W Weiner
Journal:  Magn Reson Med       Date:  2001-05       Impact factor: 4.668

3.  Frontal lobe function in amyotrophic lateral sclerosis: a neuropsychologic and positron emission tomography study.

Authors:  A C Ludolph; K J Langen; M Regard; H Herzog; B Kemper; T Kuwert; I G Böttger; L Feinendegen
Journal:  Acta Neurol Scand       Date:  1992-02       Impact factor: 3.209

4.  Reanalysis of multislice (1)H MRSI in amyotrophic lateral sclerosis.

Authors:  N Schuff; W D Rooney; R Miller; D F Gelinas; D L Amend; A A Maudsley; M W Weiner
Journal:  Magn Reson Med       Date:  2001-03       Impact factor: 4.668

5.  Early detection and longitudinal changes in amyotrophic lateral sclerosis by (1)H MRSI.

Authors:  J Suhy; R G Miller; R Rule; N Schuff; J Licht; V Dronsky; D Gelinas; A A Maudsley; M W Weiner
Journal:  Neurology       Date:  2002-03-12       Impact factor: 9.910

6.  MR imaging and localized proton spectroscopy of the precentral gyrus in amyotrophic lateral sclerosis.

Authors:  B C Bowen; P M Pattany; W G Bradley; J B Murdoch; F Rotta; A A Younis; R C Duncan; R M Quencer
Journal:  AJNR Am J Neuroradiol       Date:  2000-04       Impact factor: 3.825

7.  Frontal lobe dysfunction in amyotrophic lateral sclerosis.

Authors:  I Evdokimidis; T S Constantinidis; P Gourtzelidis; N Smyrnis; I Zalonis; P V Zis; E Andreadou; C Papageorgiou
Journal:  J Neurol Sci       Date:  2002-03-15       Impact factor: 3.181

8.  Volumetric analysis reveals corticospinal tract degeneration and extramotor involvement in ALS.

Authors:  C M Ellis; J Suckling; E Amaro; E T Bullmore; A Simmons; S C Williams; P N Leigh
Journal:  Neurology       Date:  2001-11-13       Impact factor: 9.910

9.  Immunohistochemical localization of N-acetylaspartate in rat brain.

Authors:  J R Moffett; M A Namboodiri; C B Cangro; J H Neale
Journal:  Neuroreport       Date:  1991-03       Impact factor: 1.837

10.  Cognitive impairment in amyotrophic lateral sclerosis: evidence from neuropsychological investigation and event-related potentials.

Authors:  Hasmet A Hanagasi; I Hakan Gurvit; Numan Ermutlu; Gulustu Kaptanoglu; Sacit Karamursel; Halil A Idrisoglu; Murat Emre; Tamer Demiralp
Journal:  Brain Res Cogn Brain Res       Date:  2002-08
View more
  28 in total

1.  Advances in the application of MRI to amyotrophic lateral sclerosis.

Authors:  Martin R Turner; Michel Modo
Journal:  Expert Opin Med Diagn       Date:  2010-11

Review 2.  The present and the future of neuroimaging in amyotrophic lateral sclerosis.

Authors:  F Agosta; A Chiò; M Cosottini; N De Stefano; A Falini; M Mascalchi; M A Rocca; V Silani; G Tedeschi; M Filippi
Journal:  AJNR Am J Neuroradiol       Date:  2010-04-01       Impact factor: 3.825

3.  The size distribution of neurons in the motor cortex in amyotrophic lateral sclerosis.

Authors:  Mette Helene Toft; Ole Gredal; Bente Pakkenberg
Journal:  J Anat       Date:  2005-10       Impact factor: 2.610

4.  Neurochemical correlates of functional decline in amyotrophic lateral sclerosis.

Authors:  Ian Cheong; Dinesh K Deelchand; Lynn E Eberly; Małgorzata Marjańska; Georgios Manousakis; Gaurav Guliani; David Walk; Gülin Öz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-11-22       Impact factor: 10.154

5.  Presymptomatic spinal cord neurometabolic findings in SOD1-positive people at risk for familial ALS.

Authors:  J D Carew; G Nair; P M Andersen; J Wuu; S Gronka; X Hu; M Benatar
Journal:  Neurology       Date:  2011-09-21       Impact factor: 9.910

6.  Proton magnetic resonance spectroscopy in patients with early stages of amyotrophic lateral sclerosis.

Authors:  Stefan Sivák; Michal Bittšanský; Egon Kurča; Monika Turčanová-Koprušáková; Milan Grofik; Vladimír Nosál'; Hubert Poláček; Dušan Dobrota
Journal:  Neuroradiology       Date:  2010-04-06       Impact factor: 2.804

7.  Voxel-based morphometry study of brain volumetry and diffusivity in amyotrophic lateral sclerosis patients with mild disability.

Authors:  F Agosta; E Pagani; M A Rocca; D Caputo; M Perini; F Salvi; A Prelle; M Filippi
Journal:  Hum Brain Mapp       Date:  2007-12       Impact factor: 5.038

8.  Ultra-High Field Proton MR Spectroscopy in Early-Stage Amyotrophic Lateral Sclerosis.

Authors:  Ian Cheong; Małgorzata Marjańska; Dinesh K Deelchand; Lynn E Eberly; David Walk; Gülin Öz
Journal:  Neurochem Res       Date:  2017-04-03       Impact factor: 3.996

9.  Gray matter perfusion correlates with disease severity in ALS.

Authors:  Randall R Rule; Norbert Schuff; Robert G Miller; Michael W Weiner
Journal:  Neurology       Date:  2010-02-10       Impact factor: 9.910

Review 10.  25 years of neuroimaging in amyotrophic lateral sclerosis.

Authors:  Bradley R Foerster; Robert C Welsh; Eva L Feldman
Journal:  Nat Rev Neurol       Date:  2013-08-06       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.